Market price today
Tricida, Inc. (TCDA) Stock Price & Analysis
Gross Profit Margin
Operating Profit Margin
Net Profit Margin
Return on Assets
Return on Equity
Return on Capital Employed
Company general description and statistics
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California. On January 11, 2023, Tricida, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Return on Investments
Frequently Asked Question
How many company shares are outstanding in 2023?
There are stock number shares outstanding of Tricida, Inc. (TCDA) on the NASDAQ in 2023.
What is P/E ratio of enterprise in 2023?
The current P/E ratio of enterprise is -0.070 in 2023.
What is the ticker symbol of Tricida, Inc. stock?
The ticker symbol of Tricida, Inc. stock is TCDA.
What is company IPO date?
IPO date of Tricida, Inc. is 2018-06-28.
What is company current share price?
Current share price is 0.108 USD.
What is stock market cap today?
The market cap of stock today is 6267056.000.
What is PEG ratio in 2023?
The current -0.002 is -0.002 in 2023.
What is the number of employees in 2023?
In 2023 the company has 57.